Pigment cell & melanoma researchHumansAnimalsVitiligoB7-H1 AntigenProgrammed Cell Death 1 Receptor
PD-1/PD-L1 Checkpoint Dysfunction in Vitiligo: Novel Pathogenic Insights and Therapeutic Innovation.
Heba Ahmed, Hanan R Nada, Ahmed Mourad, Laila A Rashed, Ghada M El-Hanafy, Nermeen M A Abdallah, Mohamed M Abdelhady
Published: 202510.1111/pcmr.70067
Abstract
Vitiligo, a chronic autoimmune disorder characterized by progressive melanocyte destruction, remains challenging to treat due to an incomplete understanding of underlying immune mechanisms. Recent clinical observations from cancer immunotherapy have…
Preview only. Read the full abstract at the source